에빅스젠
2 known investors
Find your way into 에빅스젠
Avixgen develops therapeutic treatments for ophthalmological diseases such as macular degeneration and dry eye, inflammatory conditions including atopic dermatitis, and an in-house drug delivery platform called ACP technology.
Founders & leadership
한
한성준
Investors · 2
Frequently asked questions
- What does 에빅스젠 do?
- Avixgen develops therapeutic treatments for ophthalmological diseases such as macular degeneration and dry eye, inflammatory conditions including atopic dermatitis, and an in-house drug delivery platform called ACP technology.
- Who are 에빅스젠's investors?
- 에빅스젠's investors include LB Investment, Hyundai Venture Investment Corporation.